If you liked this article you might like

'Mad Money' Lightning Round: Gilead Sciences, Celgene, Express Scripts
Jim Cramer's 'Mad Money' Recap: Investors See Washington Going Pro-Business
Latest Tech IPO Filings Could Be Signs of an Overheated Market
Acacia CEO: Demand Is Still Red-Hot for Our Products